KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Payables (2017 - 2026)

ClearPoint Neuro's Payables history spans 14 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Payables fell 6.27% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 6.27% decrease, with the full-year FY2025 number at $1.3 million, down 6.27% from a year prior.
  • Payables hit $1.3 million in Q4 2025 for ClearPoint Neuro, up from $723000.0 in the prior quarter.
  • Over the last five years, Payables for CLPT hit a ceiling of $10.8 million in Q1 2024 and a floor of $272000.0 in Q4 2022.
  • Historically, Payables has averaged $2.0 million across 5 years, with a median of $1.2 million in 2021.
  • Biggest five-year swings in Payables: soared 748.47% in 2024 and later crashed 88.75% in 2025.
  • Tracing CLPT's Payables over 5 years: stood at $427000.0 in 2021, then crashed by 36.3% to $272000.0 in 2022, then surged by 44.49% to $393000.0 in 2023, then skyrocketed by 240.97% to $1.3 million in 2024, then dropped by 6.27% to $1.3 million in 2025.
  • Business Quant data shows Payables for CLPT at $1.3 million in Q4 2025, $723000.0 in Q3 2025, and $1.5 million in Q2 2025.